英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

scansion    
n. 韵律节奏的分析,按韵律诵读

韵律节奏的分析,按韵律诵读

scansion
n 1: analysis of verse into metrical patterns

Scansion \Scan"sion\, n. [L. scansio, fr. scandere, scansum, to
climb. See {Scan}.] (Pros.)
The act of scanning; distinguishing the metrical feet of a
verse by emphasis, pauses, or otherwise.
[1913 Webster]


请选择你想看的字典辞典：
单词字典翻译
Scansion查看　Scansion　在百度字典中的解释百度英翻中〔查看〕
Scansion查看　Scansion　在Google字典中的解释Google英翻中〔查看〕
Scansion查看　Scansion　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • ZORYVE® (roflumilast) | Official Patient Website
    ZORYVE cream 0 3% is a prescription medicine used on the skin (topical), including in areas with skin folds, to treat plaque psoriasis in adults and children 6 years of age and older
  • Roflumilast: Uses, Application, and Side-effects — DermNet
    Roflumilast is a phosphodiesterase-4 (PDE4) inhibitor used for the treatment of COPD and plaque psoriasis Topical roflumilast 0 3% cream (Zorvye™) was approved by the FDA in 2022 for the treatment of plaque psoriasis in patients aged 12 years and older
  • Roflumilast in Dermatology: A Newer Phosphodiesterase-4 . . .
    Roflumilast is approximately 25–300 times more potent than apremilast and crisaborole and has a much greater affinity to block PDE-4 [5] Topical roflumilast 0 3% cream was approved by the US FDA for the treatment of plaque psoriasis in July 2022 [6]
  • Zoryve: Uses, Dosage, Side Effects Warnings - Drugs. com
    Zoryve cream is used to treat plaque psoriasis and atopic dermatitis, and Zoryve foam is used for seborrheic dermatitis and plaque psoriasis Includes Zoryve side effects, dose, directions, and indications
  • Roflumilast (ZORYVE) Cream in Plaque Psoriasis
    FDA Approval Information Description Mechanism of Action Roflumilast is a phosphodiesterase-4 inhibitor previously approved for the oral treatment of adults with severe chronic obstructive pulmonary disease under the brand name DALIRESP (AstraZeneca) Roflumilast was approved in a cream formulation in July 2022
  • Zoryve (roflumilast) - Uses, Side Effects, and More - WebMD
    How Zoryve Cream Works for Plaque Psoriasis Zoryve may also be used for other conditions as determined by your healthcare provider
  • FDA Approves Arcutis’ ZORYVE™ (Roflumilast) Cream 0. 3% For . . .
    First and only topical PDE4 inhibitor approved for the treatment of plaque psoriasis, including intertriginous psoriasis Approved for once-daily treatment in mild, moderate, and severe plaque psoriasis with no limitations on duration of use Established efficacy – provides rapid clearance of plaques
  • Treatment for plaque psoriasis | ZORYVE® (roflumilast) 0. 3% . . .
    Have you already been prescribed ZORYVE (roflumilast) topical foam 0 3% for plaque psoriasis? I agree to receive occasional information from Arcutis Biotherapeutics about their products, services, programs, and or other marketing information and agree to let Arcutis Biotherapeutics use the contact information provided for this purpose
  • Trial of Roflumilast Cream for Chronic Plaque Psoriasis
    Systemic oral phosphodiesterase type 4 (PDE-4) inhibitors have been effective in the treatment of psoriasis Roflumilast cream contains a PDE-4 inhibitor that is being investigated for the topical
  • FDA Approves Roflumilast Topical Foam 0. 3% for Plaque . . .
    Key Takeaways Roflumilast topical foam 0 3% is FDA-approved for plaque psoriasis in patients aged 12 and older, effective for body and scalp treatment It is a once-daily, steroid-free PDE4 inhibitor, increasing proinflammatory mediators and decreasing anti-inflammatory mediators





中文字典-英文字典  2005-2009